Miotics.
D000109:Acetylcholine / Q000627:therapeutic use; D000867:Anterior Chamber; D002217:Carbachol / Q000627:therapeutic use; D002386:Cataract / Q000139:chemically induced; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use; D003560:Cysts / Q000139:chemically induced; D004456:Echothiophate Iodide / Q000627:therapeutic use; D005901:Glaucoma / Q000188:drug therapy; D006261:Headache / Q000139:chemically induced; D006801:Humans; D007531:Isoflurophate / Q000627:therapeutic use; D008688:Methacholine Compounds / Q000627:therapeutic use; D008916:Miotics / Q000009:adverse effects / Q000627:therapeutic use; D009216:Myopia / Q000139:chemically induced; D009388:Neostigmine / Q000627:therapeutic use; D010146:Pain / Q000139:chemically induced; D010275:Parasympathetic Nervous System / Q000187:drug effects; D010277:Parasympathomimetics / Q000627:therapeutic use; D010830:Physostigmine / Q000627:therapeutic use; D010862:Pilocarpine / Q000627:therapeutic use; D000644:Quaternary Ammonium Compounds / Q000627:therapeutic use; D012163:Retinal Detachment / Q000139:chemically induced; D013035:Spasm / Q000139:chemically induced; D013285:Strabismus / Q000188:drug therapy; D014605:Uveitis / Q000139:chemically induced
D002800:Cholinesterase Inhibitors; D008688:Methacholine Compounds; D008916:Miotics; D010277:Parasympathomimetics; D000644:Quaternary Ammonium Compounds; D010862:Pilocarpine; D007531:Isoflurophate; D009388:Neostigmine; D002217:Carbachol; D010830:Physostigmine; D004456:Echothiophate Iodide; D000109:Acetylcholine